On December 22, 2021, the Food and Drug Administration (FDA) published draft guidance documents for manufacturers of devices that were issued Emergency Use Authorizations (EUAs) or were subject to ...
On February 22, 2022, the U.S. Food and Drug Administration (FDA) hosted a webinar on two draft guidance documents for the transition plans for medical devices commercialized pursuant to either ...
With the COVID-19 public health emergency set to expire May 11, the FDA is preparing to prevent any supply disruptions to medical devices after three years of shortages partly spurred by the pandemic.
The Centers for Medicare and Medicaid Services has finalized its rule easing reimbursement for medical device makers. Called Transitional Coverage for Emerging Technologies, the program gives device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results